Loading organizations...
§ Venture Capital · Cambridge, MA, USA
Private equity firm making control investments in lower middle market companies; consumer, business services, industrial, chemicals.
Delos Capital is a New York-based private equity firm that makes control investments in lower middle market companies across North America. The investment organization primarily focuses on the consumer, business services, industrial, and chemicals sectors, while also participating in seed through Series B funding rounds for fintech, e-commerce, and software-as-a-service startups. The firm specifically targets established businesses generating earnings before interest, taxes, depreciation, and amortization between $5 million and $25 million. To date, the financial entity has managed at least three closed investment vehicles, including the April 2018 close of Delos Investment Fund II. The current leadership team features experienced financial professionals with backgrounds at major institutions like Apollo Global Management, alongside key executives such as Chief Financial Officer Eileen Kavanagh and Partner Michael Rakiter. Delos Capital was founded in 2013 by Matthew Constantino and Andrew Schweibold.
Key people at Delos Capital.
Key people at Delos Capital.
Delos Capital is a New York-based private equity firm founded in 2013 that specializes in management buyouts, recapitalizations, and growth investments primarily targeting lower middle market companies across the United States[1][4]. The firm’s mission centers on delivering tailored investment solutions by leveraging deep industry expertise and close collaboration with management teams to maximize alignment and outcomes[3]. Delos Capital’s investment philosophy emphasizes complex, cutting-edge transactions where their involvement can add significant value, focusing on sectors where they can drive growth and operational improvements. While the firm broadly invests across industries, its portfolio includes companies in healthcare and life sciences, reflecting a commitment to supporting innovations that improve patient outcomes[2]. Delos Capital plays a meaningful role in the startup and growth ecosystem by providing capital and strategic guidance that enable companies to scale and innovate.
Delos Capital was co-founded by Managing Partners Matt Constantino and Andrew Schweibold, both bringing decades of experience in private equity and financial advisory[5]. Schweibold, who returned to the firm in 2024, has a background with Apollo Global Management and Lazard, while Ari Lefkovits, another Managing Partner who joined in 2024, has extensive experience in capital solutions and restructuring from his time at Lazard[5]. Alice Chong and Jay Losty round out the leadership team, bringing expertise in restructuring, M&A, and complex financing[5]. The firm has evolved to focus on lower middle market companies, leveraging its founders’ deep networks and transaction experience to identify and support promising businesses[4].
Delos Capital operates at the intersection of private equity and growth investing during a period when lower middle market companies are increasingly attractive due to their growth potential and need for capital and operational expertise. The firm benefits from market forces such as increased demand for specialized capital solutions and a growing emphasis on innovation in healthcare and technology sectors[2]. By focusing on complex transactions, Delos Capital fills a niche that larger funds may overlook, thus influencing the broader ecosystem by enabling mid-sized companies to scale and innovate effectively.
Looking ahead, Delos Capital is poised to continue leveraging its deep expertise and network to capitalize on opportunities in the lower middle market, particularly in sectors like life sciences where innovation is accelerating[2]. Trends such as increased healthcare innovation, demand for specialized financing, and the evolving needs of mid-sized companies will shape their investment strategy. As the firm expands its portfolio and influence, it may deepen its role as a key enabler of growth-stage companies, potentially broadening its sector focus while maintaining its core strength in complex, value-added investments.
This positions Delos Capital as a dynamic private equity firm that combines seasoned leadership with a strategic focus on transformative investments, driving impact across the companies it partners with and the broader market.
Delos Capital has 17 tracked investments across 11 companies. The latest tracked deal is $8.0M Seed in STRM in January 2026.
